Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2021-11-03 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Orexo for the third quarter of 2021. It contains comprehensive financial statements, including income statements, cash flow data, and key performance indicators (EBIT, EBITDA, net sales) for the quarter and year-to-date periods. It also includes management commentary, business updates, and forward-looking statements. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). Q3 2021
2021-11-03 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Q3 2021 Interim Report' and contains comprehensive financial data, including income statements, balance sheet items, and management commentary on business performance for the third quarter of 2021. It is not a mere announcement or certification, but the full interim financial report itself, fitting the definition of an Interim / Quarterly Report (IR). Q3 2021
2021-11-03 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport Kv 2 2021' (Interim Report Q2 2021) for the company Orexo. It contains comprehensive financial statements, including income statements, cash flow data, and key performance indicators for the period. It also includes management commentary (VD kommentar) and operational updates. Since it is a full quarterly financial report containing substantive financial data and analysis, it is classified as an Interim/Quarterly Report. Q2 2021
2021-07-16 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Q2 2021 Interim Report' and contains comprehensive financial statements, including income statements, cash flow data, and management commentary on business performance for the second quarter of 2021. It meets the criteria for an Interim/Quarterly Report as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2021
2021-07-16 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding for 'HealthCap ORX Holdings KB' in 'Orexo AB'. It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, including percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ'. The document is a direct notification of a change in ownership threshold, not a general regulatory filing (RNS) or a report announcement (RPA).
2021-05-17 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Q1 2021 from Orexo. It contains comprehensive financial statements, including income statements, cash flow data, and key performance indicators (EBIT, EBITDA, net sales) for the specified period. It also includes management commentary, business updates, and forward-looking statements. It is not a short announcement, but a full quarterly report. Q1 2021
2021-04-29 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.